December 09, 2014

Symphogen A/S Licenses the Selexis SUREtechnology Expression Platform and Cell Line

Read More
July 30, 2014

Selexis SA to Present New Data and a Case Study at IBC’s Cell Line Development and Engineering Conference

Read More
June 24, 2014

Cook Pharmica, LLC and Selexis SA Establish Customized Biologic Drug Development and Manufacturing Services Platform

Read More
June 05, 2014

Selexis SA to Showcase Revolutionary Advancements in Protein Expression Technologies at BIO 2014

Read More
May 30, 2014

Selexis SA CEO to Speak at the BioProcess Theater at BIO 2014

Read More
April 23, 2014

Selexis SA to Speak on Overcoming Complex Difficult-to-Express ProteinSecretion Bottlenecks at the 2014 Protein Engineering Summit (PEGS)

Read More
March 26, 2014

Selexis SA to Speak at the the Human Antibodies and Hybridomas (HAH2014) Conference

Read More
February 27, 2014

“Pre-Clinical Advancements to Reduce Attrition Rates in Biologic Drug Discovery”

Read More
February 25, 2014

Selexis SA to Partner at BIO-Europe Spring

Read More
February 20, 2014

Selexis Announces Expansion of R&D License Agreement with Amgen

Read More
January 13, 2014

Opthea Signs Cell Line Development Commercial License Agreement with Selexis SA for Wet AMD Product

Read More
January 13, 2014

Opthea Signs Cell Line Development Commercial License Agreement with Selexis SA for Wet AMD Product

Read More